$SKIN ($SKIN) posted quarterly earnings results for Q4 2025 on Thursday, March 12th. The company reported earnings of -$0.06 per share, missing estimates of -$0.05 by $0.01. The company also reported revenue of $82,400,000, beating estimates of $79,312,711 by $3,087,289.
You can see Quiver Quantitative's $SKIN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$SKIN Hedge Fund Activity
We have seen 54 institutional investors add shares of $SKIN stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 3,225,668 shares (+127.0%) to their portfolio in Q4 2025, for an estimated $4,483,678
- MIRABELLA FINANCIAL SERVICES LLP added 3,114,986 shares (+20.0%) to their portfolio in Q4 2025, for an estimated $4,329,830
- JANUS HENDERSON GROUP PLC removed 2,692,940 shares (-91.3%) from their portfolio in Q4 2025, for an estimated $3,743,186
- OWLS NEST PARTNERS IA, LLC removed 1,109,629 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,542,384
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,990,000
- WOODLINE PARTNERS LP removed 610,130 shares (-10.3%) from their portfolio in Q4 2025, for an estimated $848,080
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 608,288 shares (-50.2%) from their portfolio in Q4 2025, for an estimated $845,520
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SKIN Price Targets
Multiple analysts have issued price targets for $SKIN recently. We have seen 3 analysts offer price targets for $SKIN in the last 6 months, with a median target of $1.65.
Here are some recent targets:
- Oliver Chen from TD Cowen set a target price of $1.65 on 01/21/2026
- Sydney Wagner from Jefferies set a target price of $1.6 on 01/14/2026
- George Kelly from Roth Capital set a target price of $3.5 on 09/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
